Skip to the page

Data / Form D filings / Proxima Bio, Inc.

Proxima Bio, Inc.: Form D filings

Proxima Bio, Inc., a health care company in New York, NY, filed 2 Form D notices with the SEC in 2026. The latest, on June 10, 2026, reports $91.5 million sold of a $91.5 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
116 E 16TH STREET FLOOR 12, New York, NY, 10003
Phone
(212) 516-8509
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2104665

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 10, 2026Amendment$91,454,999$91,454,99911Jan 12, 2026sec.gov
Jan 21, 2026New notice$88,500,025$86,264,999$2,235,02611Jan 12, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Zachary CarpenterExecutive Officer, Director
John McFarlandExecutive Officer
Alex GasnerDirector
Jason PontinDirector

Other health care companies in New York that filed recently

Every Form D from the week of Jun 8, 2026 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Proxima Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.